Media Newsroom of

NephroSant

QiSant™ Initial Publication Demonstrates Strong Clinical Validation of Urine-Based Assay in Kidney Transplant Surveillance

QiSant™ Initial Publication Demonstrates Strong Clinical Validation of Urine-Based Assay in Kidney Transplant Surveillance

NephroSant, a startup company that is focused on redefining kidney health, today announced the landmark publication showing high accuracy for a urine-based assay for the surveillance of kidney transplant patients to identify rejection.  The study was published in Science Translational…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login